The emergence of variants of HIV PR resistant to small-molecule PR inhibitors is well documented. While strategies involving combinations of inhibitors may eventually block the emergence of resistant variants, we have pursued an alternative approach to protease inhibition that may be less sensitive to point mutations. Molecular modeling is used to design defective HIV PR monomers which exert a dominant-negative (d-n) inhibitory effect, presumably leading to the formaion of catalytically defective protease heterodimers in vivo, and ultimately yielding non-infectious viral particles. A PR variant containing three amino acid changes D25K, G49W and I50W (KWW) was the most effective d-n inhibitor assayed in cultured cells. Gene therapy vectors, in combination with potent vector-producing cell lines, have been successfully used to deliver our KWW PR inhibitor to PBMCs along with other d-n inhibitors of HIV-1 replication (e.g., RevM10). Virus challenge assays of these cells shows that up to a 1.5 log protection is afforded by the expression of the KWW variant (against HIV-1 IIIB). Additional virus challenge assays are in progress. Our goal is to develop the HIV PR d-n inhibitor as a potential gene therapy tool while using HIV PR as a model system for the study of protein-protein interactions and to gain an understanding of dominant-negative interference of protein function. We are also using the yeast two-hybrid system to characterize the strength of interaction between wt and variant HIV PR monomers to better understand the mechanism of dominant-negative HIV-1 PR inhibition and the protein-protein interactions responsible for this inhibition in addition to developing our macromolecular PR inhibitors for potential application in vivo.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Biotechnology Resource Grants (P41)
Project #
5P41RR001081-21
Application #
6280285
Study Section
Project Start
1998-07-01
Project End
1999-06-30
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
21
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Kozak, John J; Gray, Harry B; Garza-López, Roberto A (2018) Relaxation of structural constraints during Amicyanin unfolding. J Inorg Biochem 179:135-145
Alamo, Lorenzo; Pinto, Antonio; Sulbarán, Guidenn et al. (2018) Lessons from a tarantula: new insights into myosin interacting-heads motif evolution and its implications on disease. Biophys Rev 10:1465-1477
Viswanath, Shruthi; Chemmama, Ilan E; Cimermancic, Peter et al. (2017) Assessing Exhaustiveness of Stochastic Sampling for Integrative Modeling of Macromolecular Structures. Biophys J 113:2344-2353
Chu, Shidong; Zhou, Guangyan; Gochin, Miriam (2017) Evaluation of ligand-based NMR screening methods to characterize small molecule binding to HIV-1 glycoprotein-41. Org Biomol Chem 15:5210-5219
Portioli, Corinne; Bovi, Michele; Benati, Donatella et al. (2017) Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications. J Biomed Mater Res A 105:847-858
Alamo, Lorenzo; Koubassova, Natalia; Pinto, Antonio et al. (2017) Lessons from a tarantula: new insights into muscle thick filament and myosin interacting-heads motif structure and function. Biophys Rev 9:461-480
Nguyen, Hai Dang; Yadav, Tribhuwan; Giri, Sumanprava et al. (2017) Functions of Replication Protein A as a Sensor of R Loops and a Regulator of RNaseH1. Mol Cell 65:832-847.e4
Sofiyev, Vladimir; Kaur, Hardeep; Snyder, Beth A et al. (2017) Enhanced potency of bivalent small molecule gp41 inhibitors. Bioorg Med Chem 25:408-420
Nekouzadeh, Ali; Rudy, Yoram (2016) Conformational changes of an ion-channel during gating and emerging electrophysiologic properties: Application of a computational approach to cardiac Kv7.1. Prog Biophys Mol Biol 120:18-27
Towse, Clare-Louise; Vymetal, Jiri; Vondrasek, Jiri et al. (2016) Insights into Unfolded Proteins from the Intrinsic ?/? Propensities of the AAXAA Host-Guest Series. Biophys J 110:348-361

Showing the most recent 10 out of 508 publications